Immediate Impact
24 standout
Citing Papers
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer
2023 Standout
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
2023 Standout
Works of Abdulkadir İskender being referenced
Endocrine Therapy, New Biologicals, and New Study Designs for Presurgical Studies in Breast Cancer
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Abdulkadir İskender | 185 | 146 | 41 | 46 | 21 | 320 | |
| W Zulmi | 110 | 40 | 138 | 23 | 21 | 332 | |
| Mukesh Kumar | 165 | 135 | 26 | 81 | 22 | 344 | |
| L. van Leeuwen | 157 | 191 | 25 | 10 | 21 | 332 | |
| Bernardo Marzano | 145 | 125 | 76 | 70 | 13 | 312 | |
| Yan Huang | 104 | 24 | 82 | 27 | 23 | 331 | |
| Daelim Jee | 145 | 112 | 59 | 19 | 25 | 295 | |
| Bora Lee | 163 | 46 | 34 | 27 | 32 | 281 | |
| Hongqiang Jiang | 107 | 35 | 25 | 21 | 23 | 327 | |
| Thomas B. Dougherty | 165 | 79 | 141 | 18 | 17 | 314 | |
| Keiichiro Imanaka | 39 | 77 | 122 | 91 | 16 | 345 |
All Works
Login with ORCID to disown or claim papers
Loading papers...